Chief Executive Officer Marc Hertz and Chief Scientific Officer Vipin Kumar to present on translating immune biology and clinical signals into novel therapeutic approaches for IPF LA JOLLA, CA, Sept.

SYDNEY, Sept. 16, 2026 (GLOBE NEWSWIRE)-- Cambium Bio Limited (ASX: CMB) ("Cambium Bio" or the "Company"), a clinical-stage regenerative medicine company developing biologic therapies for ...

Joanna Jabłczyńska po otrzymaniu pisma przedsądowego od Katarzyny Grocholi otworzyła zbiórkę na rzecz Fundacji Rak'n'Roll. Udało jej się zebrać ponad pół miliona złotych. Teraz poinformowała o ...

MANILA, Philippines — Face-to-face classes are suspended in parts of Luzon on Thursday, September 10, amid heavy rains brought by the persistence of the southwest monsoon, locally known as habagat.

World-class founding team includes Prof. Georg Schett, MD, a renowned expert in rheumatology, immunology, and B cell biology, alongside scientific co-founder and board member Frank Nestle, MD, Partner ...

To help BridgeBio ramp up for the launch of three new medicines, plus approved ATTR-CM med Attruby, Sixth Street and HealthCare Royalty have agreed to invest up to $1 billion in the California biotech ...

Merck KGaA has agreed to put up $73 per share in cash to acquire Bio-Techne Corporation, which works out to a total consideration of roughly $11.3 billion for the Minneapolis-based provider and ...

Our academic team here at Careers360 comprises experienced experts with years of teaching experience who have developed these NCERT Solutions for Class 10 Maths based on the modified NCERT syllabus.

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...

Johnson & Johnson JNJ-1.86%decrease; down pointing triangle has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline. J&J on ...

HOLMDEL, N.J., April 28, 2026 (GLOBE NEWSWIRE)-- BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today ...

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors ...